New guide to market entry for medical devices

How can you ensure your medical device innovation enters the right market and meets the necessary regulations? Leeanne Baker advises on the pros and cons of the regulatory scenarios in key international markets (the UK, the US and Europe).

For medical device manufacturers deciding on which market to place their medical device first can be a make or break; the market chosen needs to present a real need for the device, it needs to provide a stable regulatory and economic environment and also should be one that the device is ready to enter without too much delay or additional investment.

With extensive experience supporting both established businesses wanting to enter new markets and new start-ups, IMed Consultancy has pooled the intelligence of its team of experts to draft a guide that summarises key pros and cons of entering a specific market before others. The helpful guide focuses on three major markets that are typically being weighed up by manufacturers wanting to export their devices: the EU, the US and the UK.

The global medical devices market is undergoing a period of profound transformation. With advancements in medical technology, the development and deployment of innovative devices have brought forth immense opportunities for improving patient care and revolutionising the healthcare industry. 

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

AfPP Annual Conference 2024

University of Warwick
2nd - 3rd August 2024

The Operating Theatres North Show 2024

Etihad Stadium, Manchester
12th September 2024

The AfPP Roadshow - London

Cavendish Conference Centre, London
14th September 2024

Clinical Engineering Conference

Radisson Blu Stansted Hotel
17th September 2024

Infection Prevention 2024

ICC Birmingham
23rd - 25th September 2024